On International Women's Day, we are delighted to announce that we have closed our Pre-Series A funding to enhance development of our #ovariancancer test (and beyond).
@QubisLtd @ClarendonFM @DeepbridgeCap @QubPGJCCR #IWD23
Great news for the team from Belfast-based @GenoME_Dx.
They’ve just secured investment to support further development of their novel testing technology.
startacus.net/culture/genome…
On #InternationalWomensDay we wish to congratulate our Chief Operations Officer @sbeattie134 on receiving a Women in Innovation award @innovateuk #OvarianCancer #earlydetection
theguardian.com/society/2022…
Awareness and Action are #PowerfulTogether so #NoWomanLeftBehind #EarlyDiagnosisSavesLives
@BreakthroCancer @isgoppi @ovacare @ovariancancerco @NOCC_National @targetovarian @OvarianCancerUK @eveappeal @grace_women @IGCSociety @WHICoalition @QubPGJCCR #WOCD21 #TEAlights
By 2040 we will see an ↑ in #ovariancancer by 42% and mortality by 50%. Tools for screening and early diagnosis are needed now so #NoWomanLeftBehind. Follow us here genomediagnostics.co.uk for more info on our novel #liquidbiopsy for earlier and more accurate diagnosis of OC
By 2040 we will see an ↑ in #ovariancancer by 42% and mortality by 50%. Tools for screening and early diagnosis are needed now so #NoWomanLeftBehind. Follow us here genomediagnostics.co.uk for more info on our novel #liquidbiopsy for earlier and more accurate diagnosis of OC
As a new @QUBelfast @QubPGJCCR spinout, our work stems from a decade of research. We are developing a novel blood test to improve on CA125 for earlier and more accurate diagnosis of #OvarianCancer to improve patient outcome! #WOCD21
On World Ovarian Cancer day, GenoME Diagnostics are delighted to launch our website and social media platforms. Follow us here genomediagnostics.co.uk for more info on our development of a novel blood test for earlier and more accurate diagnosis of OC! #WOCD21 @OvarianCancerDY


